German biotech startup Ovo Labs has developed new technologies to “rejuvenate” human eggs during in vitro fertilisation (IVF), potentially boosting the chances of conception. The first baby was born via IVF more than 40 years ago. Since then, the technology has helped millions of women get pregnant. However, IVF can put significant emotional, psychological, and financial strain on patients. It is often unsuccessful on the first attempt. Some try multiple times without success, leaving many couples unable to have children at all. Ovo Labs wants to improve the odds. Based on 20 years of fertility research, the startup has developed…
This story continues at The Next WebRead More